Anna Sophia McKenney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Sophia McKenney has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Ciléin Kearns
Radiology Department, Wellington Regional Hospital, Wellington, New Zealand
2 shared publications - Kapil Wattamwar
Department of Radiology, Montefiore Medical Center, Bronx, New York
2 shared publications Aaron T. Wild
Department Southeast Radiation Oncology, Levine Cancer Institute, Charlotte, North Carolina
1 shared publicationAditya Khurana
Mayo Clin, Dept Radiol, Rochester, MN USA
1 shared publication- Ahmed M. Gabr
Department of Interventional Radiology, OHSU and Tanta University, Portland, USA
1 shared publication - Alan C. Legasto
Department of Radiology, NewYork-Presbyterian/Weill Cornell Medicine, New York, NY
1 shared publication
Latest Publications
- 1 July 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (7) , e240116
Minimally Invasive Interventions in the Thorax for Tumor Treatment and Palliation
Interventional radiologic procedures, both percutaneous and endovascular, have an important role in thoracic tumor diagnosis, treatment, and symptom palliation through numerous established and evolving interventions.
- 1 July 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (7) , e240116
Minimally Invasive Interventions in the Thorax for Tumor Treatment and Palliation
Interventional radiologic procedures, both percutaneous and endovascular, have an important role in thoracic tumor diagnosis, treatment, and symptom palliation through numerous established and evolving interventions.
- 10 November 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (3) , 407-408
Engaging IR Trainees in the Academic Publishing Editorial Process
- 10 November 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (3) , 407-408
Engaging IR Trainees in the Academic Publishing Editorial Process
- 1 November 2023
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 5 (6) , e230176
Mentorship in Radiology Research: A Guide for Mentors and Mentees
- 1 November 2023
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 5 (6) , e230176
Mentorship in Radiology Research: A Guide for Mentors and Mentees
- 1 March 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (3) , e220184
Noteworthy: Taking Notes for Radiology Training and Beyond
- 1 March 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (3) , e220184
Noteworthy: Taking Notes for Radiology Training and Beyond
- 1 October 2022
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 42 (6) , E167-E168
Klippel-Trenaunay Syndrome
- 1 October 2022
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 42 (6) , E167-E168
Klippel-Trenaunay Syndrome
- Open Access
- 6 February 2022
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 8 (1) , 100916
Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
- 6 February 2022
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 8 (1) , 100916
Open AccessRadiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
- Open Access
- 30 October 2021
- Published by Springer Nature in European Radiology
- Vol. 32 (4) , 2661-2671
COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes?
Objective To determine whether the degree of parenchymal involvement on chest radiograph (CXR) at the time of COVID-19 diagnosis and its early radiologic evolution can predict adverse events including hospitalization, intubation, and death in patients with cancer. Methods Retrospective study of 627 COVID-19-positive patients between March and April 2020, of which 248 had baseline CXR within 72 h of diagnosis and 64 patients had follow-up wihtin72 h. CXRs were classified as abnormal (i.e., radiologic findings suggestive of COVID-19 infection were noted), normal, or indeterminate. Baseline and follow-up severity scores were calculated based on lung regions in abnormal CXRs. Statistical analysis was performed to determine associations between abnormal CXR or severity score with adverse events. Results Of 248 patients (median age = 65) with a baseline CXR, 172/248 (69%) had an abnormal baseline study, which was associated with hospitalization (p < 0.001), intubation (p = 0.001), and death (p = 0.005). For patients with solid neoplasms, when adjusted for stage, it was associated with hospitalization (p = 0.0002), intubation (p = 0.019), and death (p = 0.03). The median baseline severity score was 3 (range = 1–10); the greater the score, the higher the likelihood of adverse outcome (p < 0.003 for all). A baseline severity score > 9 predicted > 50% probability of intubation and a score of ≥ 10 predicted > 50% of probability of death. The baseline severity score was not correlated with cancer-related treatment. Early radiologic progression was not correlated with hospitalization, intubation, or death. Conclusion The degree of parenchymal involvement on CXR within 72 h of COVID-19 diagnosis is associated with adverse outcomes in patients with cancer. Key Points • In patients with cancer, the presence and severity of radiologic manifestation of COVID-19 on chest radiographs within 72 h of COVID-19 diagnosis are associated with hospitalization, intubation, and death. • Early radiologic progression on chest radiographs is not correlated with adverse outcomes.
- 30 October 2021
- Published by Springer Nature in European Radiology
- Vol. 32 (4) , 2661-2671
Open AccessCOVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes?
Objective To determine whether the degree of parenchymal involvement on chest radiograph (CXR) at the time of COVID-19 diagnosis and its early radiologic evolution can predict adverse events including hospitalization, intubation, and death in patients with cancer. Methods Retrospective study of 627 COVID-19-positive patients between March and April 2020, of which 248 had baseline CXR within 72 h of diagnosis and 64 patients had follow-up wihtin72 h. CXRs were classified as abnormal (i.e., radiologic findings suggestive of COVID-19 infection were noted), normal, or indeterminate. Baseline and follow-up severity scores were calculated based on lung regions in abnormal CXRs. Statistical analysis was performed to determine associations between abnormal CXR or severity score with adverse events. Results Of 248 patients (median age = 65) with a baseline CXR, 172/248 (69%) had an abnormal baseline study, which was associated with hospitalization (p < 0.001), intubation (p = 0.001), and death (p = 0.005). For patients with solid neoplasms, when adjusted for stage, it was associated with hospitalization (p = 0.0002), intubation (p = 0.019), and death (p = 0.03). The median baseline severity score was 3 (range = 1–10); the greater the score, the higher the likelihood of adverse outcome (p < 0.003 for all). A baseline severity score > 9 predicted > 50% probability of intubation and a score of ≥ 10 predicted > 50% of probability of death. The baseline severity score was not correlated with cancer-related treatment. Early radiologic progression was not correlated with hospitalization, intubation, or death. Conclusion The degree of parenchymal involvement on CXR within 72 h of COVID-19 diagnosis is associated with adverse outcomes in patients with cancer. Key Points • In patients with cancer, the presence and severity of radiologic manifestation of COVID-19 on chest radiographs within 72 h of COVID-19 diagnosis are associated with hospitalization, intubation, and death. • Early radiologic progression on chest radiographs is not correlated with adverse outcomes.
- 1 September 2021
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 41 (5) , E147-E148
Clostridium Septicum Aortitis
- 1 September 2021
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 41 (5) , E147-E148
Clostridium Septicum Aortitis
- 1 September 2021
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 41 (5) , E142-E144
Addressing Global Radiology Disparities: Increasing Access to Interventional Radiology Education
- 1 September 2021
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 41 (5) , E142-E144
Addressing Global Radiology Disparities: Increasing Access to Interventional Radiology Education
- 1 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 2 (6) , e200464
Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York City
Background Coronavirus disease 2019 (COVID-19) affects vulnerable populations (VP) adversely. Purpose To evaluate overall imaging utilization in vulnerable subgroups (elderly, racial/ethnic minorit...
- 1 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 2 (6) , e200464
Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York City
Background Coronavirus disease 2019 (COVID-19) affects vulnerable populations (VP) adversely. Purpose To evaluate overall imaging utilization in vulnerable subgroups (elderly, racial/ethnic minorit...